Luminescent probe method in the study of the interaction of glycated human serum albuminwith non-glycated human serum albumin

Background and Objectives: The development and functioning of all living beings ends with the inevitable aging process, as a result of which the activity of all organs and the body as a whole is suppressed, which leads to imminent death. Protein glycation is considered to be one of the causes of aging. This process takes place throughout life, but it intensifies with age. Protein glycation is a reaction of covalent coupling of free amino groups of proteins and reducing carbohydrates, which proceeds without the participation of enzymes and leads to disruption of protein functions. This process is unregulated, as it occurs without the participation of biological catalysts. As a result of glycation of proteins in humans, inflammatory processes occur in the body and a number of diseases such as heart attack, stroke, atherosclerosis, cataract, glycemia, Alzheimer’s disease, diabetes mellitus, etc. develop. In the tasks of medical diagnostics, methods of monitoring the state of proteins in the human body are necessary. In this regard, the work is devoted to the study of the processes of interaction of human serum albumin globules (HSA) with globules of human glycated serum albumin (gHSA). Materials and Methods: In conducting a study of the spectral-kinetic characteristics of the eosin luminescent probe in solutions of glycated and non-glycated HSA, as well as in a mixture of glycated and non–glycated HSA, an exponential dependence of the second order was used to approximate the dependencies of DF (delayed fluorescence) and PHOS (phosphorescence), and an anisotropy equation was used to assume the formation of the gHSA-HSA complex. Results: It has been found that the intensity and kinetics of quenching of delayed fluorescence and phosphorescence of the eosin fluorescent probe associated with proteins are sensitive to the ratio of glycated and non-glycated proteins in solution. To explain the increase in the intensity and lifetime of eosin phosphorescence during the transition from a solution of HSA to a mixture of HSA and gHSA, it is assumed that the globules of HSA and gHSA form a complex of the composition of gHSA-HSA, as a result of diffusion encounters. The rotational mobility of this complex is much less than the separate globules of HSA and gHSA. The formation of the complex is confirmed by an increase in the anisotropy of delayed fluorescence and phosphorescence of eosin in a mixture of HSA and gHSA. Conclusion: The obtained results of the work can be used to diagnose the presence of a complex of glycated with non-glycated proteins in human blood plasma.&nbsp

Dolosigranulum pigrum modulates immunity against SARS-CoV-2 in respiratory epithelial cells

In a previous work, we demonstrated that nasally administered Dolosigranulum pigrum 040417 beneficially modulated the respiratory innate immune response triggered by the activation of Toll-like receptor 3 (TLR3) and improved protection against Respiratory Syncytial Virus (RSV) in mice. In this work, we aimed to evaluate the immunomodulatory effects of D. pigrum 040417 in human respiratory epithelial cells and the potential ability of this immunobiotic bacterium to in-crease the protection against Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). The respiratory commensal bacterium D. pigrum 040417 differentially modulated the production of IFN-β, IL-6, CXCL8, CCL5 and CXCL10 in the culture supernatants of Calu-3 cells stimulated with poly(I:C) or challenged with SARS-CoV-2. The differential cytokine profile induced by the 040417 strain was associated with a significant reduction in viral replication and cellular damage after coronavirus infection. Of note, D. pigrum 030918 was not able to modify the resistance of Calu-3 cells to SARS-CoV-2 infection, indicating a strain-specific immunomodulatory effect for respiratory commensal bacteria. The findings of this work improve our understanding of the immunological mechanisms involved in the modulation of respiratory immunity induced by respiratory commensal bacteria, by demonstrating their specific effect on respiratory epithelial cells. In addition, the results suggest that particular strains such as D. pigrum 040417 could be used as a promising alternative for combating SARS-CoV-2 and reducing the severity of COVID-19.Fil: Islam, Md Aminul. Tohoku University; Japón. Bangladesh Agricultural University; BangladeshFil: Albarracín, Leonardo Miguel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; ArgentinaFil: Melnikov, Vyacheslav. Gabrichevsky Research Institute for Epidemiology and Microbiology; RusiaFil: Andrade, Bruno G. N.. Munster Technological University; IrlandaFil: Cuadrat, Rafael R. C.. Berlín Institute for Medical Systems Biology; AlemaniaFil: Kitazawa, Haruki. Tohoku University; JapónFil: Villena, Julio Cesar. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentin

Новые комбинации и названия сосудистых растений Азиатской России.

In this paper, we present nomenclatural novelties required in the course of the preparation of the second, revised version of the checklist of vascular plants of Asian Russia. The first version was published in 2012 (Baikov 2012). At the family level, we accepted the modern classification systems (APG IV for flowering plants, PPG I for lycophytes and ferns, and GPG for gymnosperms). At the genus level, we follow the generic concepts applied for particular taxonomic groups according to the Catalogue of Life (COL; https://www.catalogueoflife.org/), version COL23.5. At the species level, we consistently apply the monotypic species concept (also known in Russia as Komarov’s concept). In total, this paper presents one new nothogenus name (× Sibirotrisetokoeleria Chepinoga nom. nov., Poaceae) and 156 new names in the rank of species, in 28 families: Amaranthaceae Juss. (1 name), Amaryllidaceae J. St.-Hil. (1), Apiaceae Lindl. (2), Asteraceae Bercht. & J.Presl (12), Boraginaceae Juss. (4), Caryophyllaceae Juss. (11), Crassulaceae J. St.-Hill. (3), Cyperaceae Juss. (8), Ericaceae Juss. (2), Fabaceae Lindl. (16), Gentianaceae Juss. (1), Geraniaceae Juss. (1), Juncaceae Juss. (1), Lamiaceae Martinov (1), Menyanthaceae Dumort. (1), Orchidaceae Juss. (1), Orobanchaceae Vent. (1), Papaveraceae Juss. (4), Plantaginaceae Juss. (1), Poaceae Barnhart (49), Polygonaceae Juss. (4), Primulaceae Batsch. ex Borkh. (6), Ranunculaceae Juss. (4), Rosaceae Juss. (5), Salicaceae Mirb. (2), Saxifragaceae Juss. (11), Vitaceae Juss. (1), Zygophyllaceae R. Br. (2 names)

S-layer protein 2 of 'Lactobacillus crispatus' 2029, its structural and immunomodulatory characteristics and roles in protective potential of the whole bacteria against foodborne pathogens

We have previously demonstrated that human vaginal Lactobacillus crispatus 2029 (LC2029) strain is highly adhesive to cervicovaginal epithelial cells, exhibits antagonistic activity against genitourinary pathogens and expresses surface-layer protein (Slp). The aims of the present study were elucidation of Slp structural and immunomodulatory characteristics and its roles in protective properties of the whole vaginal LC2029 bacteria against foodborne pathogens. Enteric Caco-2 and colon HT-29 cell lines were used as the in vitro models of the human intestinal epithelial layer. LC2029 strain has two homologous surface-layer (S-layer) genes, slp1 and slp2. Whilst we found no evidence for the expression of slp1 under the growth conditions used, a very high level of expression of the slp2 gene was detected. C-terminal part of the amino sequence of Slp2 protein was found to be highly similar to that of the conserved C-terminal region of SlpA protein of L. crispatus Zj001 isolated from pig intestines and CbsA protein of L. crispatus JCM5810 isolated from chicken intestines, and was substantially variable at the N-terminal and middle regions. The amino acid sequence identity between SlpA and CbsA was as high as 84%, whilst the identity levels of these sequences with that of Slp2 were only 49% and 50% (respectively). LC2029 strain was found to be both acid and bile tolerant. Survival in simulated gastric and intestinal juices of LC2029 cells unable to produce Slp2 was reduced by 2-3 logs. Vaginal L. crispatus 1385 (LC1385) strain not expressing Slp was also very sensitive to gastric and intestinal stresses. Slp2 was found to be non-covalently bound to the surface of the bacterium, acting as an adhesin and facilitating interaction of LC2029 lactobacilli with the host immature or fully differentiated Caco-2 cells, as well as HT-29 cells. No toxicity to or damage of Caco-2 or HT-29 epithelial cells were detected after 24 h of colonization by LC2029 lactobacilli. Both Slp2 protein and LC2029 cells induced NF-kB activation in Caco-2 and HT-29 cells, but did not induce expression of innate immunity mediators Il-8, Il-1β, and TNF-α. Slp2 and LC2029 inhibited Il-8 production in Caco-2 and HT-29 cells induced by MALP-2 and increased production of anti-inflammatory cytokine Il-6. Slp2 inhibited production of CXCL1 and RANTES by Caco-2 cells during differentiation and maturation process within 15 days. Culturing Caco-2 and HT-29 cells in the presence of Slp2 increased adhesion of bifidobacteria BLI-2780 to these enterocytes. Upon binding to Caco-2 and HT-29 cells, Slp2 protein and LC2029 lactobacilli were recognized by toll-like receptors (TLR) 2/6. It was shown that LC2029 strain is a strong co-aggregator of foodborne pathogens Campylobacter jejuni, Salmonella enteritidis, and Escherichia coli O157:H used in this study. The Slp2 was responsible for the ability of LC2029 to co-aggregate these enteropathogens. Slp2 and intact LC2029 lactobacilli inhibited foodborne pathogen-induced activation of caspase-9 and caspase-3 as apoptotic biomarkers in Caco-2 and HT-29 cells. In addition, Slp2 and Slp2-positive LC2029 strain reduced adhesion of tested pathogenic bacteria to Caco-2 and HT-29 cells. Slp2-positive LC2029 strain but not Slp2 alone provided bactericidal effect on foodborne pathogens. These results suggest a range of mechanisms involved in inhibition of growth, viability, and cell adhesion properties of pathogenic Proteobacteria by the Slp2 producing LC2029, which may be useful in treatment of necrotizing enterocolitis (NEC) in newborns and foodborne infectious diseases in children and adults, increasing the colonization resistance and maintaining the intestinal homeostasis

'Limosilactobacillus fermentum' Strain 3872 : antibacterial and immunoregulatory properties and synergy with prebiotics against socially significant antibiotic-resistant infections of animals and humans

Limosilactobacillus fermentum strain 3872 (LF3872) was originally isolated from the breast milk of a healthy woman during lactation and the breastfeeding of a child. The high-quality genome sequencing of LF3872 was performed, and a gene encoding a unique bacteriocin was discovered. It was established that the bacteriocin produced by LF3872 (BLF3872) belongs to the family of cell-wall-degrading proteins that cause cell lysis. The antibacterial properties of LF3872 were studied using test cultures of antibiotic-resistant Gram-positive and Gram-negative pathogens. Gram-positive pathogens (Staphylococcus aureus strain 8325-4 and S. aureus strain IIE CI-SA 1246) were highly sensitive to the bacteriolytic action of LF3872. Gram-negative pathogens (Escherichia coli, Salmonella strains, and Campylobacter jejuni strains) were more resistant to the bacteriolytic action of LF3872 compared to Gram-positive pathogens. LF3872 is a strong co-aggregator of Gram-negative pathogens. The cell-free culture supernatant of LF3872 (CSLF3872) induced cell damage in the Gram-positive and Gram-negative test cultures and ATP leakage. In the in vitro experiments, it was found that LF3872 and Actigen prebiotic (Alltech Inc., Nicholasville, KY, USA) exhibited synergistic anti-adhesive activity against Gram-negative pathogens. LF3872 has immunoregulatory properties: it inhibited the lipopolysaccharide-induced production of proinflammatory cytokines IL-8, IL-1β, and TNF-α in a monolayer of Caco-2 cells; inhibited the production of IL-12 and stimulated the production of IL-10 in immature human dendritic cells; and stimulated the production of TGF-β, IFN-γ, and IgA in the immunocompetent cells of intestinal Peyer’s patches (PPs) in mice. These results indicate the possibility of creating a synbiotic based on LF3872 and a prebiotic derived from Saccharomyces cerevisiae cell wall components. Such innovative drugs and biologically active additives are necessary for the implementation of a strategy to reduce the spread of antibiotic-resistant strains of socially significant animal and human infections

Draft Genome Sequence of Corynebacterium pseudodiphtheriticum strain 090104 "Sokolov"

This report describes the first draft genome sequence of a Corynebacterium pseudodiphtheriticum strain. The information on the genome organization and putative gene products will assist in better understanding of the molecular mechanisms involved in the beneficial probiotic effects of this bacterium

Draft Genome Sequence of Lactobacillus crispatus 2029.

This report describes a draft genome sequence of Lactobacillus crispatus 2029. The reads generated by the Ion Torrent PGM were assembled into contigs with a total size of 2.2 Mb. The data were annotated using the NCBI GenBank and RAST servers. A comparison with the reference strain revealed specific features of the genome

Draft genome sequence of Bacillus amyloliquefaciens B-1895.

In this report, we present a draft genome sequence of Bacillus amyloliquefaciens strain B-1895. Comparison with the genome of a reference strain demonstrated similar overall organization, as well as differences involving large gene clusters